CA
NZ
UK
AU
IND
US
Stryker (SEC CIK 310764) is a diversifiedMedTechgiant organized around two broad segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. Its portfolio spans surgical instruments, hospital equipment, neurovascular devices, trauma and joint-replacement implants, and - most visibly - the Mako robotic-arm platform used in orthopedic …
Nutriband (SEC CIK 1676047) is a pharmaceutical company focused on transdermal and topical products. Its centerpiece is the AVERSA abuse-deterrent transdermal technology, designed to be incorporated into patches - most prominently an abuse-deterrent fentanyl patch - to help deter misuse, diversion and accidental exposure. …
Headquartered in Las Vegas, Nevada, PharmaCyte Biotech built its early identity around "Cell-in-a-Box," a live-cell encapsulation technology once positioned for pancreatic cancer and other indications. In recent years the company has shifted decisively away from clinical spending and toward what it frames as tactical …
Emergent BioSolutions is a life-sciences company built around public-health preparedness. Its portfolio spans the CYFENDUS and BioThrax anthrax vaccines, the ACAM2000 smallpox and mpox vaccine, botulism antitoxin (BAT), and the over-the-counter NARCAN naloxone nasal spray used to reverse opioid overdoses. Much of its revenue …
Cardio Diagnostics is a precision-cardiovascular-medicine company that combines epigenetics, genetics and artificial intelligence, using DNA-methylation biomarkers andMachine Learningto assess and detect coronary heart disease. Its core products are the Epi+Gen CHD risk-assessment test and the PrecisionCHD detection test, alongside its HeartRisk and CardioInnovate360 offerings. …
Bolt Biotherapeutics develops cancer immunotherapies built on its Boltbody Immune-Stimulating Antibody Conjugate, or ISAC, platform, which pairs tumor-targeting antibodies with immune-activating payloads. Its lead candidate, BDC-4182, is a next-generation ISAC targeting claudin 18.2 for gastric and gastroesophageal junction cancers, and it is advancing through …
Decoy Therapeutics develops AI-designed peptide-conjugate therapeutics through its IMP3ACT platform, which it uses to create what it calls Designable Multi-Antivirals, or D-MAVs, single drugs engineered to work across multiple viruses rather than one at a time. The company says it targets more than 250 …
Scopus BioPharma (SEC CIK 1772028) built its identity around developing novel therapeutics, with early programs positioned in immuno-oncology and gene-based medicine. The company completed a Nasdaq listing in late 2020 and, over the following years, pursued corporate restructuring and transactions involving its subsidiary assets. …
TransMedics (SEC CIK 1756262) develops and commercializes the Organ Care System (OCS), a portable platform designed to keep donor hearts, lungs and livers in a functioning, near-physiologic state outside the body rather than on traditional cold storage. The company has paired that hardware with …
GARRISON FILM PRODUCTIONS INC presents itself, by name, as a film and entertainment company - a sector mismatch relative to the health and technology theme under which the ticker was flagged. A full-text search of the SEC's EDGAR system returns no filings under that …
Please wait processing your request...